Florian van Bömmel

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. doi request reprint Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
    Florian van Bömmel
    Medizinische Klinik m S Hepatologie und Gastroenterologie Charité, Campus Virchow Klinikum, Universitatsmedizin Berlin, Germany
    Hepatology 51:73-80. 2010
  2. ncbi request reprint Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
    Florian van Bömmel
    Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charite, Universitatsmedizin Berlin, Campus Virchow, Berlin, Germany
    Hepatology 40:1421-5. 2004
  3. ncbi request reprint Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
    Florian van Bömmel
    Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charite Campus Virchow Klinikum, Universitatsmedizin Berlin, Berlin, Germany
    Hepatology 44:318-25. 2006
  4. doi request reprint Bezafibrate maintenance therapy in patients with advanced chronic hepatitis C
    Viola Knop
    University Hospital Charite, Campus Virchow Klinikum, Department of Gastroenterology and Hepatology, Berlin, Germany
    Eur J Gastroenterol Hepatol 25:594-600. 2013

Detail Information

Publications4

  1. doi request reprint Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues
    Florian van Bömmel
    Medizinische Klinik m S Hepatologie und Gastroenterologie Charité, Campus Virchow Klinikum, Universitatsmedizin Berlin, Germany
    Hepatology 51:73-80. 2010
    ..Loss of HBeAg occurred in 24% of patients and HBsAg loss occurred in 3%. No significant adverse events were noticed during TDF monotherapy...
  2. ncbi request reprint Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
    Florian van Bömmel
    Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charite, Universitatsmedizin Berlin, Campus Virchow, Berlin, Germany
    Hepatology 40:1421-5. 2004
    ..In conclusion, tenofovir may become an effective alternative for the treatment of patients with lamivudine-resistant HBV infection...
  3. ncbi request reprint Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
    Florian van Bömmel
    Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charite Campus Virchow Klinikum, Universitatsmedizin Berlin, Berlin, Germany
    Hepatology 44:318-25. 2006
    ..No side effects were reported. In conclusion, these preliminary observations strongly suggest that TDF might be a highly effective rescue drug for HBV-infected patients with altered responsiveness to treatment with lamivudine and ADV...
  4. doi request reprint Bezafibrate maintenance therapy in patients with advanced chronic hepatitis C
    Viola Knop
    University Hospital Charite, Campus Virchow Klinikum, Department of Gastroenterology and Hepatology, Berlin, Germany
    Eur J Gastroenterol Hepatol 25:594-600. 2013
    ..The aim of the present study was to assess the efficacy and safety of bezafibrate in patients with advanced chronic hepatitis C...